<DOC>
	<DOCNO>NCT02331563</DOCNO>
	<brief_summary>A total 60 adult patient American Society Anesthesiologists physical status I , II , III randomize Group B ( n = 30 ) receive TAP block 0.25 % bupivacaine Group D ( n = 30 ) 0.5 mcg/kg dexmedetomidine add 0.25 % bupicavaine follow general anaesthesia . Total local anaesthetic volume standardise 20 ml side abdomen . Hemodynamic responses surgical incision intraoperative fentanyl consumption note . Visual analog scale ( VAS ) score assessed emergence , 1 , 2 , 3 , 4 , 5 , 6 24 h. Time first rescue analgesic ( VAS â‰¥4 cm demand ) , duration postoperative analgesia , incidence postoperative nausea-vomiting also note .</brief_summary>
	<brief_title>Adjuvant Effect Dexmedetomidine Ultrasound ( USG ) Guided Transvers Abdominis Plane Block</brief_title>
	<detailed_description>Transversus abdominis plane ( TAP ) block show provide postoperative pain relief follow various abdominal inguinal surgery . The aim randomise control trial ass effect transversus abdominis plane ( TAP ) block opioid requirement median hospitai stay , postoperative nause vomitting patient undergo laparoscopic cholecystectomy .</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>The patient undergoing laparascopic cholecystectomy Story allergy bupivacaine dexmedetomidine The surgery preceeded laparatomy Recent abdominal operation history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>dexmedetomidine</keyword>
</DOC>